| scholarly article | Q13442814 |
| P5530 | Altmetric DOI | 10.1182/BLOOD-2015-06-652263 |
| P6179 | Dimensions Publication ID | 1064122742 |
| P356 | DOI | 10.1182/BLOOD-2015-06-652263 |
| P932 | PMC publication ID | 4608241 |
| P698 | PubMed publication ID | 26324704 |
| P1154 | Scopus EID | 2-s2.0-84944200239 |
| P50 | author | Yiming Wang | Q42158068 |
| Heyu Ni | Q42158077 | ||
| Cedric Duval | Q52584539 | ||
| Robert A S Ariëns | Q53843830 | ||
| Caroline E Hansen | Q64882406 | ||
| Jcm Meijers | Q68093274 | ||
| Alisa S. Wolberg | Q86111693 | ||
| P2093 | author name string | Susan T Lord | |
| Wilbur A Lam | |||
| Jill M Johnsen | |||
| Martha A Clark | |||
| Byungwook Ahn | |||
| James R Byrnes | |||
| Micah J Mooberry | |||
| P2860 | cites work | Fibrin fibers have extraordinary extensibility and elasticity | Q30479919 |
| The mechanical properties of single fibrin fibers. | Q30497764 | ||
| Plasma fibronectin supports hemostasis and regulates thrombosis | Q30590791 | ||
| Changes in the properties of normal human red blood cells during in vivo aging | Q33796195 | ||
| Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. | Q33856100 | ||
| The elasticity of an individual fibrin fiber in a clot | Q33879142 | ||
| Factor XIII activity mediates red blood cell retention in venous thrombi | Q33944224 | ||
| Venous thrombosis | Q89217812 | ||
| α-α Cross-links increase fibrin fiber elasticity and stiffness | Q34120791 | ||
| Structural origins of fibrin clot rheology | Q34171813 | ||
| Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology. | Q34171820 | ||
| Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum | Q34598503 | ||
| Thrombin generation and fibrin clot structure | Q34598931 | ||
| Molecular mechanisms affecting fibrin structure and stability | Q34759786 | ||
| Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice | Q35001664 | ||
| Crosslinking and labeling of membrane proteins by transglutaminase-catalyzed reactions | Q35083581 | ||
| Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice. | Q35346495 | ||
| Platelet retraction force measurements using flexible post force sensors | Q37032473 | ||
| Elevated prothrombin promotes venous, but not arterial, thrombosis in mice. | Q37189156 | ||
| Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability | Q37450566 | ||
| Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. | Q37623550 | ||
| Factor XIII: a coagulation factor with multiple plasmatic and cellular functions | Q37899674 | ||
| Factor XIII deficiency: an update. | Q38127624 | ||
| Modification of human erythrocyte ghosts with transglutaminase | Q39066804 | ||
| Mechanics and contraction dynamics of single platelets and implications for clot stiffening | Q39756732 | ||
| Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot | Q41825512 | ||
| Involvement of fibrinogen specific binding in erythrocyte aggregation | Q41858099 | ||
| The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis | Q41938756 | ||
| Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes | Q42929227 | ||
| Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation | Q44059567 | ||
| Integrin-associated protein (CD47) is a putative mediator for soluble fibrinogen interaction with human red blood cells membrane | Q44159019 | ||
| Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia | Q45862883 | ||
| High dose factor VIIa improves clot structure and stability in a model of haemophilia B. | Q45889198 | ||
| The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. | Q45906428 | ||
| Roles of fibrin α- and γ-chain specific cross-linking by FXIIIa in fibrin structure and function. | Q52840471 | ||
| Purification and characterization of recombinant human fibrinogen. | Q54248130 | ||
| Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. | Q54489366 | ||
| Novel Factor XIII Probes for Blood Coagulation Imaging | Q58816212 | ||
| Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk | Q61405268 | ||
| Titration of the acceptor cross-linking sites in fibrin | Q65000361 | ||
| Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition | Q67316135 | ||
| Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule | Q70039500 | ||
| The binding of fibrinogen and fibrinogen degradation products to the erythrocyte membrane and its relationship to haemorheology | Q71021514 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS) | Q72841203 | ||
| The effect of plasma antithrombin concentration on thrombin generation and fibrin gel structure | Q72841358 | ||
| Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X | Q77501904 | ||
| Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions | Q77871735 | ||
| Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor | Q79105321 | ||
| Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness | Q80160260 | ||
| Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium | Q83709203 | ||
| Factor XIII stiffens fibrin clots by causing fiber compaction | Q87628289 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1940-1948 | |
| P577 | publication date | 2015-08-31 | |
| P1433 | published in | Blood | Q885070 |
| P859 | sponsor | Role of coagulation factor XIII in fibrin clot structure and thrombosis | Q60669183 |
| P1476 | title | Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking | |
| P478 | volume | 126 |
| Q58895615 | Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis |
| Q36088633 | Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile. |
| Q90181900 | Assessment of whole blood coagulation with a microfluidic dielectric sensor |
| Q38669149 | Biophysical Mechanisms Mediating Fibrin Fiber Lysis. |
| Q90516253 | Blood coagulation dissected |
| Q50048003 | ClotChip: A Microfluidic Dielectric Sensor for Point-of-Care Assessment of Hemostasis |
| Q92249524 | Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function |
| Q45873682 | Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking. |
| Q92983737 | Factor XIII deficiency does not prevent FeCl3-induced carotid artery thrombus formation in mice |
| Q89893917 | Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice |
| Q91659606 | Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy |
| Q90639294 | Feeling the Force: Measurements of Platelet Contraction and Their Diagnostic Implications |
| Q88678011 | Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention |
| Q54842287 | Fibrinogen and Fibrin in Hemostasis and Thrombosis. |
| Q58770454 | Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition |
| Q64069650 | Fibrinogen and fibrin: An illustrated review |
| Q88731805 | Immune Factors in Deep Vein Thrombosis Initiation |
| Q36443112 | Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood |
| Q36131278 | Leptospira Immunoglobulin-Like Protein B (LigB) Binds to Both the C-Terminal 23 Amino Acids of Fibrinogen αC Domain and Factor XIII: Insight into the Mechanism of LigB-Mediated Blockage of Fibrinogen α Chain Cross-Linking. |
| Q42261564 | Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice |
| Q90435643 | Mechanistic rationale for factor XIII cotreatment in haemophilia |
| Q50201615 | Morphometric characterization of fibrinogen's αC regions and their role in fibrin self-assembly and molecular organization |
| Q47938011 | New findings on venous thrombogenesis |
| Q38801273 | Newly-Recognized Roles of Factor XIII in Thrombosis |
| Q90444170 | Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a) |
| Q50146003 | Platelets Drive Thrombus Propagation in a Hematocrit and Glycoprotein VI-Dependent Manner in an In Vitro Venous Thrombosis Model |
| Q92433851 | Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity |
| Q35948493 | Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII. |
| Q48003288 | Red blood cells in thrombosis. |
| Q38811610 | Role of red blood cells in haemostasis and thrombosis |
| Q39453804 | The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits |
| Q38723930 | Transport physics and biorheology in the setting of hemostasis and thrombosis |
| Q38801282 | What Is the Biological and Clinical Relevance of Fibrin? |
| Q47761338 | When Flow Goes Slow, von Willebrand Factor Can Bind Red Blood Cells |
Search more.